ClinLife® marketplace – securely speeding up clinical trials has never been that easy!
Since its foundation 15 years ago, Clariness’ mission has been to provide patients with easy access to clinical trials. This lead to the idea to digitalize, raise awareness and build up a community around clinical trials resulting in the patient portal ClinLife®. Clariness strengthened that idea in 2018 by acquiring the study platform Viomedo – a trial marketplace active in Germany and Austria. Clariness transferred the knowledge to ClinLife®, which is active in over 50 countries and has more than 10 million visitors per year. “By using our service, customers are able to speed up the drug development process by 3 months or more. In addition, ClinLife® helps patients to find access to studies easily.”, says Michael Stadler Co-Founder of Clariness.
Although COVID-19 hit many industries really hard, it raised the awareness for clinical trials. Through ClinLife®, we solve many problems of our stakeholders: patients, pharmaceutical companies and sites. On ClinLife® marketplace, patients can easily find suitable trials, understand what the trial is about, check their eligibility and are brought in contact with the closest site – all just with a few clicks. Besides that, we are building solutions so that patients can track the progress of the trials they participated in or stay informed about their indication(s) of interest. The term “customer centricity” has been around in the industry for quite some time, now its time to take it to the next level via ClinLife® marketplace. That’s why different sponsors and sites already decided to list their study inventory on our platform, drive the enrolment for clinical trials and build up a community around it. We are looking forward to constantly improve our marketplace product in 2021! Stay tuned and spread the word!
Your ClinLife® marketplace team
Want to know how we can support your patient recruitment?
Simply get in touch with one of our experts, and we will review your study’s requirements, and develop a strategy to enroll more patients.
Insights and recourses
